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Laparoscopic liver resection for HCC in early post-operative period 
better but doubts over recurrence rates
In this 2:1 case matched study from Lee et al, 43 patients who underwent laparoscopic liver resection (LLR) for HCC were compared 
to 86 matched patient undergoing open surgery. Patients were apparently well matched for age, tumour size and tumour number 
although it is possible a type II error existed with regard to etiology of underlying liver disease. In the peri-operative period 
several benefi ts of LLR were noted. Estimated median blood loss was reduced from 700 mls to 300mls however of the six patients 
requiring conversion to open surgery, fi ve were for bleeding. Postoperatively, there was a reduction in severe complications 
(grade 3-4) in the LLR group and correspondingly a reduction in the median hospital length of stay from 7 to 5 days. In addition 
readmission rates were also signifi cantly reduced (19% vs. 2%). Histologically the tumours appeared similar and there were 
no positive margins in either group. So should LLR now be the standard of care for patients with HCC? Before answering, this 
author would suggest taking a closer look at the survival data provided by the authors. Statistically there did not appear to be a 
signifi cant difference between the groups but the recurrence free survival curve raises questions. The LLR curve would appear to 
have a 20% reduction in recurrence free survival at 20 months (p=0.119). This is of particular concern as the LLR group had a 
shorter follow up. The authors provide a balanced discussion regarding this issue but one must be concerned about a potential 
type II error minimising a signifi cant adverse fi nding. There is some evidence to support anatomical resection for HCC. Given 
these fi ndings it would seem important to assess whether the rate of anatomical resection was similar between the two groups. 
Clearly this may be hard to determine retrospectively. 
The authors should be congratulated on their careful analytical study and one hopes that liver surgeons take the time to 
analyse this paper in depth before committing open hepatic resection to the history books.
Saxon Connor
Health economic advantages for laparoscopic compared with open 
approach to left lateral sectionectomy
In many centres, a laparoscopic approach has become standard for left lateral sectionectomy.. This development has preceded the 
results of the Orange II randomized controlled trial and is based as often in surgery on technological innovation and anecdotal 
perception of benefi t. 
Prasad and colleagues from Leeds have looked at the health economics of performing left lateral sectionectomy laparoscopically 
versus open. This is not a randomized controlled trial and there may be an element of selection bias with the open group including 
more patients with tumours close to the left pedicle, however the patients are contemporaneous and the health economic analysis 
looks reasonable. The outcomes from the study show signifi cantly shorter hospital stay (laparoscopic: 3 days versus open: 7 days). 
In terms of hospital costs, those relating to theatre time were similar but laparoscopic instrumentation and disposables were more 
expensive than for open surgery. This difference was relatively small and was more than offset by the highly signifi cant reduction 
in costs associated with a shorter hospital stay for laparoscopic resection. Overall the saving was approximately £2000 per case, 
which at current rates equates to $3000 or €2650. 
Health economic arguments are increasingly important in planning and delivery of health care and this study is valuable in 
quantifying the potential saving from a change in approach. Surgeons need to be able to support innovation with business cases 
and this type of study provides a useful template for gathering evidence for support of new developments.
Stephen J Wigmore
Will there be enough HPB Surgeons in the right places?
We all meet promising medical school, residency and fellowship applicants who aspire to give back by meeting the needs of 
the underserved.  Indeed, a broad spectrum of healthcare needs exist ranging from crisis hotspots worldwide, to socioeconomic 
disparities and poor geographic  access to care.  The time may be right for HPB Surgery trainees with such noble ambitions. 
Ali et al offer an interesting view of the supply-demand realities for HPB Surgeons in the USA.  They used 6 years of National 
Inpatient Sample (NIS) data to derive observed/expected (O/E) ratios of HPB cases relative to populations for 46 of our states. 
Only 18 states achieved O/E ratios >1, indicating supply was meeting demand.  In 28 states, there were fewer HPB cases than 
could be expected based on population (O/E <1).  The authors conclude that the majority of the USA is actually underserved for 
HPB surgery, and offer a heat-map (Fig. 2) of the country to reveal it visually.  Intuition suggests this same map could represent 
the realities for many other subspecialties.  The discussion nicely covers today’s issues of regionalization in high-acuity surgery, 
distance bias and related socioeconomic disparities, and education targets to match needs.  As any future HPB surgeon might ask, 
“Will I wind up where I want to be, or where I am needed?”  Hopefully, we can train, deploy and, with society’s help, incentivize 
our successors towards a want/need O/E >1.
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